Literature DB >> 20039272

Metalloproteinases and their regulators in colorectal cancer.

Michel F P van der Jagt1, Theo Wobbes, Luc J A Strobbe, Fred C G J Sweep, Paul N Span.   

Abstract

Metalloproteinases (MPs) such as the matrix metalloproteinases (MMPs) and adamalysins (ADAMs and ADAMTS) are expressed in various stages of colorectal cancer (CRC), and some correlate with survival and prognosis. The MPs are regulated by various factors including EMMPRIN, TIMPs, and RECK. In addition, micro-RNAs are found to be relevant for both MP expression levels and CRC prognostication. Both MPs and their regulators could be potential targets for intervention and therapy in CRC. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20039272     DOI： 10.1002/jso.21462

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


  14 in total

1.  Identification of core miRNA based on small RNA-seq and RNA-seq for colorectal cancer by bioinformatics.

Authors:  Youwei Kou; Lei Qiao; Qiang Wang
Journal:  Tumour Biol       Date:  2014-11-21

2.  ADAM17 is associated with EMMPRIN and predicts poor prognosis in patients with uterine cervical carcinoma.

Authors:  Qin Xu; Mingang Ying; Guilin Chen; Ang Lin; Yunqing Xie; Noriyuki Ohara; Dongmei Zhou
Journal:  Tumour Biol       Date:  2014-05-04

3.  Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol.

Authors:  Yu-Long Shi; Tao Xu; Le-Ping Li; Xiao-Ping Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-02-08

4.  Matrix Metalloproteinase-2 Single Nucleotide Polymorphism in Egyptian Non-Hodgkin Lymphoma Patients: Correlation with Clinicopathological Characteristics and Outcome.

Authors:  Rania M Bakry; Ebtesam M El-Gezawy; Abeer M Darwish; Eman NasrEldin; Noha Gaber; Khalid A Nasif; EssamAbd El-Mohsen; Salma Mahfouz
Journal:  Indian J Hematol Blood Transfus       Date:  2018-12-07       Impact factor: 0.900

5.  EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer.

Authors:  K Boye; J M Nesland; B Sandstad; M Haugland Haugen; G M Mælandsmo; K Flatmark
Journal:  Br J Cancer       Date:  2012-07-10       Impact factor: 7.640

6.  Genetic polymorphisms of matrix metalloproteinases and clinical outcomes in colorectal cancer patients.

Authors:  Wen-Chien Ting; Lu-Min Chen; Jiunn-Bey Pao; Ying-Pi Yang; Bang-Jau You; Ta-Yuan Chang; Yu-Hsuan Lan; Hong-Zin Lee; Bo-Ying Bao
Journal:  Int J Med Sci       Date:  2013-06-15       Impact factor: 3.738

7.  Matrix metalloproteinase-2 and -7 expression in colorectal cancer.

Authors:  Seong Woo Hong; Yun Kyung Kang; Byungmo Lee; Woo Yong Lee; Yeo Gu Jang; In Wook Paik; Hyucksang Lee
Journal:  J Korean Soc Coloproctol       Date:  2011-06-30

8.  ADAMTS expression in colorectal cancer.

Authors:  Serafula Filou; Aggeliki Korpetinou; Dora Kyriakopoulou; Dimitrios Bounias; Michael Stavropoulos; Panagiota Ravazoula; Dionysios J Papachristou; Achilleas D Theocharis; Demitrios H Vynios
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

9.  Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis.

Authors:  Saeed Soleyman-Jahi; Saharnaz Nedjat; Afshin Abdirad; Niloofar Hoorshad; Reza Heidari; Kazem Zendehdel
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

10.  The role of matrix metalloproteinases in colorectal cancer.

Authors:  Anan H Said; Jean-Pierre Raufman; Guofeng Xie
Journal:  Cancers (Basel)       Date:  2014-02-10       Impact factor: 6.639
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.